Clearside Biomedical (CLSD)
(Delayed Data from NSDQ)
$3.76 USD
-0.13 (-3.34%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $3.81 +0.05 (1.33%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
CLSD 3.76 -0.13(-3.34%)
Will CLSD be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CLSD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CLSD
Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Beats Revenue Estimates
Compugen (CGEN) Reports Q2 Loss, Lags Revenue Estimates
CLSD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Clearside Biomedical (CLSD) Upgraded to Buy: Here's What You Should Know
Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Tops Revenue Estimates
Lineage Cell (LCTX) Reports Q1 Loss, Lags Revenue Estimates
Other News for CLSD
Is CLSD about to break its pattern? NR7 shows up after sliding 3.34%
Is CLSD positioned for a breakdown? Slingshot Bearish shows up after soaring 7.76%
Is CLSD ready to move lower? New 52 Week Low shows up after gaining 1.12%
CLSD makes New 52 Week Closing Low on September 16
CLSD makes New 52 Week Closing Low on September 15